+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 0Years - 6Years
All Genders
ID02781922

Study of Autologous Cardiac Stem Cells JRM-001 After Reconstructive Surgery in Children with Single Ventricle Heart Disease

Led by Metcela Inc. · Updated on 2026-10-19

40

Participants Needed

4

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of an intracoronary injection of autologous cardiac stem cells called JRM-001 in children with a functional single ventricle, a serious heart condition, after reconstructive surgery. This trial focuses on pediatric patients scheduled for stage 2 Glenn or stage 3 Fontan surgeries who have heart failure and reduced heart function. Participants in this study will be randomly assigned to receive either a single dose of JRM-001 stem cells at 3x105 cells per kilogram of body weight or to continue with usual care without additional intervention. This is a single-blind, parallel-group study conducted by Metcela Inc. The study will follow patients for up to 12 months after treatment to monitor changes in heart function and overall health. During the study, participants will undergo assessments including MRI, echocardiograms, and cardiac catheterization at various time points to measure heart function changes such as ejection fraction and ventricular stiffness. Researchers will also evaluate heart failure symptoms, quality of life, and track any adverse events. The total study duration allows observation from baseline up to 12 months post-treatment to understand the treatments impact and safety.

CONDITIONS

Brief Title

Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial)

Research Team

M

Metcela Inc. (former Japan Regenerative Medicine Co., Ltd.)

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here